Aesthetics attended skincare company AlumierMD’s press event to celebrate the launch of the company’s new retinol serum.
Hosted at the Rosewood London hotel on February 4, the morning featured talks from Dan Hopkins, CEO of AlumierMD, Giselle Curcio, chief brand & innovation officer at AlumierMD and Mr Ash Soni, plastic surgeon and global ambassador for AlumierMD.
The talks highlighted increasing concern around oxidative ageing, with practitioners becoming more aware of its impact. Introducing IntelliRET 0.3+, Mr Soni explained that the product contains 0.3% retinol and is designed to work within the skin’s retinoid receptor environment. The company states it also includes a botanical booster, niacinamide to support barrier function and reduce sensitivity and hyaluronic acid for hydration. Additionally, palmitoyl tripeptide-38 is included to support dermal matrix components, according to the company.
Introducing the launch in relation to oxidative ageing, Hopkins explained, “The truth is that we’re ageing faster than ever before. We’re exposed to environmental stresses that didn’t exist in the past, and to remain relevant we need to recognise oxidative stress as a major cause of the visible signs of ageing patients face today. We’re anchoring our approach around oxidative ageing defence, which patients are increasingly seeking to understand in order to achieve their skincare goals.”